Ocular Surgery News
Two studies presented at the Association for Research in Vision and Ophthalmology meeting demonstrate that besifloxacin may offer potent activity and high rates of eradication against multidrug-resistant organisms responsible for many eye infections, Bausch + Lomb reported in a news release.